anti-vaccine
Mumps cases in England rocket four-fold to highest point in a decade
February 14, 2020Medical Communications, Research and Development MMR vaccine, Vaccine, anti-vaccine, pharma
The incidence of mumps in the England has reached its highest level in 10 years, prompting warnings from health officials …
Over half of all anti-vaccine ads on Facebook stem from just two advertisers
November 15, 2019Medical Communications, Research and Development Facebook, anti-vaccine, pharma
A new study has revealed that the largest share of anti-vaccine advertisements on Facebook originate from just two organisations, both …
Twitter launches new initiative to direct users towards credible information on vaccines
May 17, 2019Medical Communications Twitter, anti-vaccine, health, pharma, social media, vaccines
Twitter will now present users with a pinned tweet directing them towards reliable information on vaccines, according to a blog …
Japanese court orders public health campaigner to pay ¥3.3 million to anti-vaccine researcher
March 27, 2019Medical Communications, Research and Development HPV, Japan, anti vaxx, anti-vaccine, public health, vaccines
Dr Riko Muranaka, a researcher and journalist who has campaigned against misinformation surrounding vaccines, has been ordered to pay ¥3.3 …
Anti-vaxxers: Vaccines in the age of populism
November 6, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing anti vaccine, anti-vaccine, history, medicine, populism, vaccines
Mistrust of the establishment has fuelled anti-vaccine sentiment in recent years, and adherence has waned as a result. Louis Goss …
Parents should ignore anti-vaccine “social media fake news”, according to England’s medical chief
November 1, 2018Medical Communications England, MMR, Vaccine, anti-vaccine, fake news
England’s Chief Medical Officer Dame Sally Davies has said that the MMR vaccine is “a safe vaccination” as she encouraged …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
